Ranbaxy prevails in Ceftin lawsuit
Executive Summary
GlaxoSmithKline's Ceftin patent is valid but Ranbaxy's cefuroxime generic does not infringe, a Trenton, N.J. federal judge rules March 31 in an opinion filed under seal. Ranbaxy was the first Ceftin generic on the market in early 2002 (1"The Pink Sheet" Feb. 5, 2002, In Brief)...